Abstract
Background DNA methylation (DNAm) may play an important role in birth outcomes.
Material and Methods Genome wide DNAm was analysed in peripheral blood DNA of women at multiple time points during gestation. A novel empirical method was used to identify CpG sites with high temporal variance in methylation associating with preterm birth.
Results High variability at 1296 CpG sites from the promoter regions of 1197 genes significantly associated with PTB. These genes belonged to pathways involved in signalling by platelet derived growth factor, platelet homeostasis, collagen degradation, extracellular matrix and circadian clock.
Conclusions The findings provide novel information which might help in development of predictive biomarkers of preterm birth outcome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded by the Department of Biotechnology, Ministry of Science and Technology, Govt. of India (BT/PR9983/MED/97/194/2013) and for some components of the biorepository by the Grand Challenges India-All Children Thriving Program (supported by the Programme Management Unit), Biotechnology Industry Research Assistance Council (BIRAC/GCI/0114/03/14-ACT). PPM acknowledges support of his J. C. Bose Fellowship. JD is supported by the Research Fellowship (NET) of the University Grants Commission (UGC), India.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approvals from Institutional Ethics Committees of Gurugram Civil Hospital, Translational Health Science and Technology Institute, National Institute of Biomedical Genomics and the collaborating hospitals were obtained.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Financial disclosure: This work was funded by the Department of Biotechnology, Ministry of Science and Technology, Govt. of India (BT/PR9983/MED/97/194/2013) and for some components of the biorepository by the Grand Challenges India – All Children Thriving Program (supported by the Programme Management Unit), Biotechnology Industry Research Assistance Council (BIRAC/GCI/0114/03/14–ACT). PPM acknowledges support of his J. C. Bose Fellowship. JD is supported by the Research Fellowship (NET) of the University Grants Commission (UGC), India.
Information pertaining to writing assistance: None.
Ethical disclosure: The authors state that they have obtained appropriate institutional review board approval for all human experimental investigations. In addition, informed consent has been obtained from the participants involved in the study.
Peer Review: This article has been submitted to Epigenomics.
Data Availability
The DNA methylation data of this study and the source codes are openly available in Gene Expression Omnibus at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169338, under the study accession number GSE169338 and GitHub: https://github.com/Jagyashila/ptbmethylation respectively.